Atlas Trials

Essential Hypertension, Dyslipidemia

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Essential Hypertension, Dyslipidemia

RecordFirmDate
A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia (NCT03338426)Boryung Pharmaceutical Co., Ltd2018-01-15
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia (NCT02166814)Boryung Pharmaceutical Co., Ltd2014-08-01

Track Essential Hypertension, Dyslipidemia automatically

Every clearance here is in the API, with alerts when new ones post.